Literature DB >> 14739745

Relative utility of magnetic resonance imaging and right ventricular angiography to diagnose arrhythmogenic right ventricular cardiomyopathy.

James B White1, Ronald Razmi, Hrudaya Nath, G Neal Kay, Vance J Plumb, Andrew E Epstein.   

Abstract

INTRODUCTION: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by fibrofatty replacement of the RV myocardium. Two imaging techniques used to assess patients suspected of having ARVC are magnetic resonance imaging (MRI) and right ventricular angiography (RVA). Traditionally, RVA has played a central role in the diagnosis of ARVC, but the non-invasive nature of MRI and its unique ability to detect fatty tissue infiltration has increased its popularity as a diagnostic tool. The objective of this study was to assess the relative diagnostic accuracy of MRI and RVA for ARVC. METHODS AND
RESULTS: Seventeen patients (9 men, 8 women; ages 42 +/- 17 [range 16-78] years) with documented ventricular arrhythmias were investigated for ARVC. A positive diagnosis of ARVC was based on criteria set forth by the ISFC Working Group on Cardiomyopathies and Dysplasia. ECG-gated spin-echo and gradient-echo MR images in multiple planes and RAO/LAO RV angiograms were compared for diagnostic concordance. Based on working group criteria, 7 patients were diagnosed with ARVC. In ten patients, MRI suggested ARVC. The remaining 7 patients had no MRI findings suggestive of the disease. Four patients with MRI findings of ARVC were incorrectly diagnosed based on Task Force criteria. Conversely, 1 patient with a normal MRI met Task Force criteria for the diagnosis of ARVC. Based on RV angiograms, 7 patients had findings suggestive of ARVC. The 10 patients without AVRD (based on RVA) also did not meet the necessary criteria for diagnosis of ARVC using Task Force standards. RVA was 100% specific and 100% sensitive compared to MRI that was only 86% sensitive and 60% specific. MRI proved to be most reliable when the images demonstrated gross, lipomatous infiltration, evidenced by a large area of hyperintensity. When the results of MRI and RVA were congruent, the diagnosis was always accurate.
CONCLUSION: RVA is more sensitive and specific to diagnose ARVC diagnosis than MRI, at least until MRI protocols are better developed. MRI results are most robust when indicators of ARVC are grossly apparent. False-positive diagnosis by MRI was primarily related to perceived motion abnormalities that were not seen by RVA. One of its greatest potential assets (fat detection) did not enhance diagnostic specificity.

Entities:  

Mesh:

Year:  2004        PMID: 14739745     DOI: 10.1023/B:JICE.0000011480.66948.c3

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  29 in total

1.  Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases?

Authors:  A P Burke; A Farb; G Tashko; R Virmani
Journal:  Circulation       Date:  1998-04-28       Impact factor: 29.690

Review 2.  MR imaging of arrhythmogenic right ventricular dysplasia.

Authors:  M Midiri; M Finazzo
Journal:  Int J Cardiovasc Imaging       Date:  2001-08       Impact factor: 2.357

3.  Arrhythmogenic right ventricular dysplasia--clinical features.

Authors:  P A Rossi
Journal:  Eur Heart J       Date:  1989-09       Impact factor: 29.983

Review 4.  Arrhythmogenic right ventricular dysplasia.

Authors:  G Fontaine; F Fontaliran; J L Hébert; D Chemla; O Zenati; Y Lecarpentier; R Frank
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

5.  Arrhythmogenic right ventricular dysplasia: MR features.

Authors:  M Midiri; M Finazzo; M Brancato; E Hoffmann; G Indovina; M D Maria; R Lagalla
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

6.  Arrhythmogenic right ventricular disease: MR imaging vs angiography.

Authors:  W Auffermann; T Wichter; G Breithardt; K Joachimsen; P E Peters
Journal:  AJR Am J Roentgenol       Date:  1993-09       Impact factor: 3.959

7.  Magnetic resonance imaging in right ventricular dysplasia.

Authors:  C Ricci; R Longo; L Pagnan; L Dalla Palma; B Pinamonti; F Camerini; R Bussani; F Silvestri
Journal:  Am J Cardiol       Date:  1992-12-15       Impact factor: 2.778

8.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?

Authors:  C Basso; G Thiene; D Corrado; A Angelini; A Nava; M Valente
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

9.  Cardioangiographic findings in patients with arrhythmogenic right ventricular dysplasia.

Authors:  C Blomström-Lundqvist; K Selin; R Jonsson; S R Johansson; D Schlossman; S B Olsson
Journal:  Br Heart J       Date:  1988-05

Review 10.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the World Heart Federation.

Authors:  D Corrado; G Fontaine; F I Marcus; W J McKenna; A Nava; G Thiene; T Wichter
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

View more
  3 in total

1.  Magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular cardiomyopathy: the gold standard or just another imaging modality?

Authors:  Irene Stevenson; Jonathan Kalman
Journal:  J Interv Card Electrophysiol       Date:  2004-02       Impact factor: 1.900

Review 2.  Complementary role of echocardiography and cardiac magnetic resonance in the non-invasive evaluation of suspected arrhythmogenic right ventricular cardiomyopathy.

Authors:  Srijita Sen-Chowdhry; Sanjay K Prasad; William J McKenna
Journal:  J Interv Card Electrophysiol       Date:  2004-08       Impact factor: 1.900

3.  Utility of cardiac magnetic resonance in the evaluation of unselected patients with possible arrhythmogenic right ventricular cardiomyopathy.

Authors:  Khang Li Looi; Colin Edwards; Hamish Hart; Jonathan P Christiansen
Journal:  Clin Med Insights Cardiol       Date:  2012-11-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.